Drug Shortage Report for AA-IPRAVENT
Report ID | 99307 |
Drug Identification Number | 02126222 |
Brand name | APO-IPRAVENT SOLUTION - INH 250MCG/ML |
Common or Proper name | IPRAVENT SOLUTION - INH 250MCG/ML |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | IPRATROPIUM BROMIDE |
Strength(s) | 250MCG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION |
Packaging size | 20 ML |
ATC code | R03BB |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-11-18 |
Estimated end date | 2019-12-01 |
Actual end date | 2019-11-29 |
Shortage status | Resolved |
Updated date | 2019-12-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-12-02 | French | Compare |
v4 | 2019-12-02 | English | Compare |
v3 | 2019-11-20 | French | Compare |
v2 | 2019-11-20 | English | Compare |
v1 | 2019-11-20 | English | Compare |
Showing 1 to 5 of 5